Abstract
Recent studies have shown that the pineal gland hormone melatonin has a variety of regulatory effects of an adaptogen with multimodal capabilities. Currently, the properties of melatonin as an anticarcinogenic agent are being actively studied. Preclinical studies have demonstrated that melatonin in combination with chemotherapeutic agents is capable of producing a synergistic effect in combination therapy for the treatment of melanoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
